Who are the key players in North America Breast Biopsy Devices Market industry?

The key players in the North America Breast Biopsy Devices Market include Hologic, Inc., Becton Dickinson and Company (BD), Devicor Medical Products (a division of Leica Biosystems), Argon Medical Devices, and Stryker Corporation. These companies are renowned for their broad product portfolios, technological innovations, and strategic market presence.

Which segment accounted for the largest North America Breast Biopsy Devices Market share?

The diagnostic segment holds the largest market share in the North America Breast Biopsy Devices Market. The rising prevalence of breast cancer, coupled with significant utilization of minimally invasive diagnostic procedures, has resulted in strong demand for breast biopsy devices across hospitals and diagnostic centers.

What are the factors driving the North America Breast Biopsy Devices Market?

Key driving factors include technological advancements in biopsy devices, rising breast cancer awareness campaigns, and favorable reimbursement policies. For instance, Stryker’s expansion of image-guided biopsy solutions in 2023 has improved both accuracy and patient outcomes, further accelerating market growth in the region.

Which type accounted for the largest North America Breast Biopsy Devices Market share?

Vacuum-assisted biopsy devices accounted for the largest market share in North America, owing to their minimally invasive nature, higher tissue yield, and improved diagnostic accuracy. These devices are preferred by clinicians and patients alike, attributing to strong adoption and significant revenue generation in recent years.

Home Healthcare

North America Breast Biopsy Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Breast Biopsy Devices Market
Brand: Bussiness Insights

North America Breast Biopsy Devices Market: by Type (Core Needle Biopsy, Fine Needle Aspiration Biopsy, Vacuum Assisted Biopsy, Surgical Biopsy, Image-Guided Biopsy), Application (Early Cancer Detection, Tumor Identification, Genetics Study, Routine Screening, Research Applications, Others), Distribution Channels (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Specialty Clinics, Retail Pharmacies, Online Sales), Technology (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy, Mammography-Guided Biopsy, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20370 | Author: Mike

RD TOC Segmentation Research Methodology Request For Free Sample

North America Breast Biopsy Devices Market (2025-2035) Outlook and Forecast

The North America Breast Biopsy Devices Market is poised for significant growth from 2025 to 2035, driven by technological advancements, growing awareness about early cancer detection, and increased prevalence of breast cancer. The market encompasses diverse device types, applications, distribution channels, technology integration, and organizational adoption across key regional markets, shaping the competitive landscape and innovation pipelines.

Latest Market Dynamics

Key Drivers

Rising incidence of breast cancer across North America, compelling demand for minimally invasive and accurate biopsy tools.
Technological advancements in image-guided biopsy devices, supported by companies like Hologic’s launch of next-generation stereotactic-guided systems.

Key Trends

Core Needle Biopsy remains the dominant device type in the North America market in 2025, accounting for the largest share due to its minimally invasive nature and diagnostic accuracy. Vacuum Assisted Biopsy is gaining ground swiftly, primarily for higher tissue yield and safety profile, while Fine Needle Aspiration and Surgical Biopsy options continue to serve select clinical scenarios. Image-guided biopsy techniques are increasingly popular in both routine and complex diagnostic settings.

Early Cancer Detection accounts for the highest application segment in the breast biopsy devices market in North America for 2025. Tumor Identification and Routine Screening collectively drive more than half of total procedure volumes as population-wide screening programs expand. Genetics Study and Research Applications are on an upward trajectory with the advancement of personalized medicine and genomic research. The market’s focus remains solidly on improving clinical outcomes through early intervention.

The North America breast biopsy devices market revenue demonstrates a steady upward trend from 2020 (USD 597 million) to an estimated USD 1,250 million by 2035. Revenue growth is propelled by high disease prevalence, ongoing technology upgrades, and expanded insurance coverage for screening and diagnostic procedures. The CAGR over this period remains robust as hospitals, diagnostic centers, and ambulatory clinics continue integrating advanced biopsy systems, contributing to substantial market expansion.

Year-on-year (YoY) growth in the North America breast biopsy devices market peaks in the mid-2020s, fueled by new product launches and growing awareness. The YoY growth rate remains above 5% annually through 2030 before moderate stabilization, reflecting market maturity and technology saturation. Nonetheless, breakthroughs in digital pathology and minimally invasive procedures sustain a healthy growth trajectory for the forecast period.

The United States holds the leading market share in breast biopsy devices for North America in 2025, attributed to high healthcare expenditure, widespread adoption of advanced diagnostics, and robust screening programs. Canada follows with expanding market penetration due to public health initiatives, while Mexico’s market share is steadily increasing as urban healthcare infrastructure develops and awareness about breast cancer rises.

Market leadership is highly competitive with Hologic, Inc. maintaining the top position in 2025, followed by Becton, Dickinson and Company and Danaher Corporation. These top three players command over half the market share, due to extensive product portfolios, investment in R&D, and established distributor networks. The market is also characterized by the presence of several prominent global and regional players, each adopting a mix of innovation and partnership strategies.

Hospitals represent the largest buyer segment in the North America breast biopsy devices market, holding a dominant share in 2025 due to high procedure volume and budget capacity for advanced systems. Diagnostic centers and ambulatory surgical centers follow, collectively driving market growth as outpatient biopsy procedures rise. Specialty clinics and retail pharmacies hold smaller shares, while online sales see modest but growing engagement.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	750
Regions	USA, Canada, Mexico
Segments	By Type, By Application, By Distribution Channel, By Technology, By Organization Size
Players	Hologic, Inc.; Becton, Dickinson and Company; Danaher Corporation; Medtronic plc; Argon Medical Devices; Stryker Corporation; Cook Medical LLC; Planmed Oy; Scion Medical Technologies; Cardinal Health; Olympus Corporation; Devicor Medical Products, Inc.; Koninklijke Philips N.V.; Siemens Healthineers AG; Others

June 2024: Hologic introduces 3D ultrasound-guided breast biopsy system for enhanced lesion targeting.
July 2024: BD unveils minimally invasive vacuum-assisted biopsy platform for outpatient use in North America.
August 2024: Siemens Healthineers launches AI-integrated imaging platform for breast biopsy diagnostics.
September 2024: Danaher’s diagnostic division partners with genomics company for expanded personalized medicine applications in breast biopsy.
October 2024: Medtronic receives FDA clearance for advanced biopsy device optimized for ambulatory surgical centers.

About the Author

Mike

Lead Industry Analyst

Mike is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Mike brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Mike has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Breast Biopsy Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Breast Biopsy Devices Market (2025-2035) Outlook and Forecast

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Breast Biopsy Devices Market Share (%) by Type, 2025

North America Breast Biopsy Devices Market Share (%) by Applications, 2025

North America Breast Biopsy Devices Market Revenue (USD Million), 2020-2035

North America Breast Biopsy Devices Market YoY (%) Growth, 2020-2035

North America Breast Biopsy Devices Market Share (%) by Region, 2025

North America Breast Biopsy Devices Market Player Share (%), 2025

North America Breast Biopsy Devices Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports